Cessation Screening Project

PHASE4CompletedINTERVENTIONAL
Enrollment

529

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

May 8, 2025

Study Completion Date

May 8, 2025

Conditions
Nicotine Dependence
Interventions
DRUG

Preparation Varenicline and Standard Duration Varenicline

16 weeks of varenicline starting 4 weeks pre-quit

DRUG

Preparation Varenicline and Extended Duration Varenicline

28 weeks of varenicline starting 4 weeks pre-quit

DRUG

Standard Duration Varenicline

12 weeks of varenicline

DRUG

Extended Duration Varenicline

24 weeks of varenicline

DRUG

Preparation Combination NRT and Standard Duration Combination NRT

16 weeks of nicotine patch + nicotine mini-lozenge starting 4 weeks pre-quit

DRUG

Preparation Combination NRT and Extended Duration Combination NRT

28 weeks of nicotine patch + nicotine mini-lozenge starting 4 weeks pre-quit

DRUG

Standard Duration Combination NRT

12 weeks of nicotine patch + nicotine mini-lozenge

DRUG

Extended Duration Combination NRT

24 weeks of nicotine patch + nicotine mini-lozenge

BEHAVIORAL

Intensive Counseling

4 phone or video counseling sessions

BEHAVIORAL

Minimal Counseling

2 brief phone or video counseling sessions

Trial Locations (2)

53233

UW Center for Tobacco Research and Intervention, Milwaukee

53711

University of Wisconsin Center for Tobacco Research and Intervention, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT04188873 - Cessation Screening Project | Biotech Hunter | Biotech Hunter